세계의 유방 재건 시장 예측(2025-2030년)

The Breast Reconstruction Market, valued at US$1,659.276 million in 2025, is projected to grow at a CAGR of 6.61% reaching a market size of US$2,285.049 million by 2030.

With the growing incidences of breast cancer globally, the market is projected to show strong growth prospects. The rising demand for immediate breast reconstruction procedures following mastectomy further allows the market to thrive in the forecast period. Furthermore, with technological advancements and companies offering varied products in the form of implants or mesh, the market for breast reconstruction holds favourable growth prospects.

Market Trends:

• Rising Breast Cancer Cases Driving Market Growth: The increasing global incidence of breast cancer is boosting demand for breast reconstruction procedures post-mastectomy. According to the WHO, 2.3 million women were diagnosed with breast cancer in 2022, many of whom are potential candidates for delayed breast reconstruction or revisions of previous reconstructions, further fueling market expansion.
• Technological Advancements in Breast Reconstruction: Innovations in breast reconstruction technology are leading to the development of more natural-looking breast implants, driving growth in the market.
• Asia-Pacific's Growth Potential: The Asia-Pacific region is expected to see significant growth in the breast reconstruction market due to rising breast cancer cases and increasing demand for reconstruction post-treatment. For instance, data from the Global Cancer Observatory shows that India reported the highest number of breast cancer cases in 2022, with 98,337 cases, highlighting the region's growing need for reconstruction solutions.
• North America's Market Leadership: North America is projected to hold a substantial share of the global breast reconstruction market, supported by advanced healthcare infrastructure and the presence of leading market players. For example, Sientra, a U.S.-based medical device company, offers FDA-approved high-strength cohesive silicone gel breast implants, available exclusively to board-certified plastic surgeons, contributing to the region's market growth.

Some of the major players covered in this report include Allergan Aesthetics, Johnson & Johnson, and Integra Lifesciences, RTI Surgical Inc., Bimini Health Tech. among others.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Breast Reconstruction Market is analyzed into the following segments:

By Type

• Implants
• Silicone Implants
• Saline Implants
• Tissue Expander

By Mastectomy

• Unilateral
• Bilateral

By End-User

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgery Centers

By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Key Findings

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. BREAST RECONSTRUCTION MARKET BY TYPE

• 5.1. Introduction
• 5.2. Implants
  • 5.2.1. Silicone Implants
  • 5.2.2. Saline Implants
• 5.3. Tissue Expander

6. BREAST RECONSTRUCTION MARKET BY MASTECTOMY

• 6.1. Introduction
• 6.2. Unilateral
• 6.3. Bilateral

7. BREAST RECONSTRUCTION MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Cosmetology Clinics
• 7.4. Ambulatory Surgery Centers

8. BREAST RECONSTRUCTION MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Type
  • 8.2.2. By Mastectomy
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Type
  • 8.3.2. By Mastectomy
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Type
  • 8.4.2. By Mastectomy
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Type
  • 8.5.2. By Mastectomy
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Type
  • 8.6.2. By Mastectomy
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. Japan
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Taiwan
    • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Johnson & Johnson Services, Inc.
• 10.2. Allergan Aesthetics
• 10.3. RTI Surgical Inc.
• 10.4. Integra LifeSciences Corporation
• 10.5. GC Aesthetics
• 10.6. Sientra, Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations